We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLHW
526
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
$2.96K ﹤0.01%
42,425
FAASW
527
DELISTED
DigiAsia Corp Warrant
FAASW
$2.92K ﹤0.01%
112,793
-24,850
-18% -$659
GDS icon
528
CALL
GDS Holdings
GDS
$6.54B
$2.92K ﹤0.01%
+14,600
New +$223K
BLEUW
529
DELISTED
bleuacacia ltd Warrants
BLEUW
$2.78K ﹤0.01%
229,691
-1,000
-0.4% -$48
CZOO.WS
530
DELISTED
Cazoo Group Ltd Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CZOO.WS
$2.75K ﹤0.01%
339,571
+314,571
+1,258% +$5.95K
CANO
531
CALL
DELISTED
Cano Health, Inc.
CANO
$2.72K ﹤0.01%
+136
New +$46K
PSFE.WS
532
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$2.71K ﹤0.01%
47,300
-2,700
-5% -$259
ASCBR
533
DELISTED
A SPAC II Acquisition Corp. Right
ASCBR
$2.69K ﹤0.01%
44,800
-30,200
-40% -$2.07K
PHYT.WS
534
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$2.66K ﹤0.01%
35,500
-200
-0.6% -$23
NSTB.WS
535
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$2.6K ﹤0.01%
+40,109
New +$1.25K
WEL.WS
536
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$2.58K ﹤0.01%
51,534
-940
-2% -$66
CEROW
537
DELISTED
CERo Therapeutics Warrants
CEROW
$2.54K ﹤0.01%
+58,905
New +$3.1K
SHAP.WS
538
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$2.54K ﹤0.01%
63,000
BFIIW
539
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
$2.51K ﹤0.01%
+53,473
New +$6.12K
LUNG icon
540
PUT
Pulmonx
LUNG
$97.1M
$2.51K ﹤0.01%
+6,700
New +$63.7K
TEVA icon
541
PUT
Teva Pharmaceuticals
TEVA
$42.5B
$2.5K ﹤0.01%
+100,000
New +$873K
RCM
542
CALL
DELISTED
R1 RCM Inc. Common Stock
RCM
$2.5K ﹤0.01%
+10,000
New +$127K
FGMCW
543
DELISTED
FG Merger Corp. Warrant
FGMCW
$2.5K ﹤0.01%
50,000
ISEE
544
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.5K ﹤0.01%
+25,000
New +$534K
APGNW
545
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$2.43K ﹤0.01%
+96,699
New +$7.74K
HAL icon
546
PUT
Halliburton
HAL
$28.2B
$2.42K ﹤0.01%
+64,400
New +$2.28M
NCACW
547
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
$2.4K ﹤0.01%
+50,000
New +$1.82K
GSDWW
548
DELISTED
Global Systems Dynamics, Inc. Warrant
GSDWW
$2.32K ﹤0.01%
46,482
-13,445
-22% -$1.53K
LITTW
549
DELISTED
Logistics Innovation Technologies Corp. Warrant
LITTW
$2.29K ﹤0.01%
56,995
-10,271
-15% -$607
PDYNW icon
550
Palladyne AI Corp Warrants
PDYNW
$177K
$2.26K ﹤0.01%
60,000
-75,881
-56% -$9.32K

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.